Table 1.

Pre- and post-treatment assessment measures of the patient groups

assessment measuresBaselineBaselineAfter 6 monthsAfter 6 months
Group IGroup IIGroup IGroup II
25(OH)D25.3 ± 4.9 ng/ml26.8 + 5.3 ng/ml36.8 + 3.9 ng/ml25.6 ± 3.4 ng/ml
FIQ47.5±5.446.7±6.727.5±6.138.5±7.3
SF-36 (Total score)47.6±10.447.0±9.961.0±5.854.8±5.3
HAD anxiety8.2±0.68.4±0.37.1±0.77.5±1.4
HADS depression8.6±0.38.6±0.97.3±0.87.7±1.4